advertisement
11.8 Neuroprotection (164)
Showing records 1 to 25
Display all abstracts in classification 11.8 Neuroprotection
Search within classification 11.8 Neuroprotection91006 Girl Power in Glaucoma: The Role of Estrogen in Primary Open Angle Glaucoma
Fotesko K
Cellular and molecular neurobiology 2022; 42: 41-57
91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
El-Nimri NW
Scientific reports 2020; 10: 21752
90934 Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Harder JM
Proceedings of the National Academy of Sciences of the United States of America 2020; 117: 33619-33627
91772 Potential neuroprotective biomolecules in ophthalmology
Afarid M
International Ophthalmology 2021; 41: 1103-1109
91500 Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
Adornetto A
Nutrients 2020; 12:
90871 Glaucoma and Antioxidants: Review and Update
Garcia-Medina JJ
Antioxidants (Basel, Switzerland) 2020; 9:
91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Zhang Y
Experimental Eye Research 2021; 204: 108449
91803 GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension
Sterling JK
Cell reports 2020; 33: 108271
91650 Role of the Internal Limiting Membrane in Structural Engraftment and Topographic Spacing of Transplanted Human Stem Cell-Derived Retinal Ganglion Cells
Zhang KY
Stem cell reports 2021; 16: 149-167
91445 Evaluating the neuroprotective impact of senolytic drugs on human vision
El-Nimri NW
Scientific reports 2020; 10: 21752
90872 ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load
Kasetti RB
Nature communications 2020; 11: 5594
91724 Ad- and AAV8-mediated gene therapy in a murine model with retinal ischemia/reperfusion injuries
Luo J
Molecular therapy. Methods & clinical development 2021; 20: 551-558
91082 Coenzyme Q and its role in glaucoma
Ahmad SS
Saudi Journal of Ophthalmology 2020; 34: 45-49
91452 Hop flower extracts mitigate retinal ganglion cell degeneration in a glaucoma mouse model
Hasegawa T
Scientific reports 2020; 10: 21653
90866 Reprogramming to recover youthful epigenetic information and restore vision
Lu Y
Nature 2020; 588: 124-129
91184 A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
Dal Monte M
International journal of molecular sciences 2020; 21:
91590 Retinal function after intravitreal injection of autologous bone marrow-derived mesenchymal stromal cells in advanced glaucoma
Vilela CAP
Documenta Ophthalmologica 2021; 143: 33-38
91304 Regulation of distinct caspase-8 functions in retinal ganglion cells and astroglia in experimental glaucoma
Yang X
Neurobiology of Disease 2021; 150: 105258
91696 Retinal oxidative stress activates the NRF2/ARE pathway: An early endogenous protective response to ocular hypertension
Naguib S
Redox biology 2021; 0: 101883
90971 Astaxanthin protects retinal ganglion cells from acute glaucoma via the Nrf2/HO-1 pathway
Li Y
Journal of chemical neuroanatomy 2020; 110: 101876
91864 Effect of Ubiquinol on Glaucomatous Neurodegeneration and Oxidative Stress: Studies for Retinal Ganglion Cell Survival and/or Visual Function
Edwards G
Antioxidants (Basel, Switzerland) 2020; 9:
91599 Gene Therapy Strategies for Glaucomatous Neurodegeneration
Lani-Louzada R
Current Gene Therapy 2021; 0:
91363 Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Tribble JR
Cells 2021; 10:
91662 Involvement of the NLRC4 inflammasome in promoting retinal ganglion cell death in an acute glaucoma mouse model
Yao K
Experimental Eye Research 2021; 203: 108388
91483 Huperzine A lowers intraocular pressure via the M3 mAChR and provides retinal neuroprotection via the M1 mAChR: a promising agent for the treatment of glaucoma
Yu P
Annals of translational medicine 2021; 9: 332